[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
this is a test
Main Menu
Journal Information::
Articles archive::
For Authors::
Contact us::
Site Facilities::
Ethical Consideration::
Search in website

Advanced Search
Receive site information
Enter your Email in the following box to receive the site news and information.
:: Volume 16, Issue 4 (Winter 2022) ::
Iranian J Nutr Sci Food Technol 2022, 16(4): 19-28 Back to browse issues page
Effects of Glutamine Supplementation against Iso Whey Protein on Clinical Symptoms and Quality of Life of the Patients with Irritable Bowel Syndrome
S Rastgoo , N Ebrahimi Daryani , A Hekmatdoost *
, a_hekmat2000@yahoo.com
Abstract:   (2917 Views)
Background and Objectives: Irritable bowel syndrome is a functional gastrointestinal disorder. Despite heavy economic and psychological burdens and severe decreases in quality of life of the patients, no certain cure is available for this common disease. Glutamine can decrease intestinal permeability and possibly improve intestinal barrier function and intestinal-friendly microbiota. Therefore, the aim of this study was to assess effects of glutamine supplementation against iso whey protein on clinical symptoms and quality of life of the patients with irritable bowel syndrome.
 Materials & Methods: This study was a double-blind, randomized clinical trial; in which, 42 patients aged 18–70 years of the two sexes were participated for six weeks. Patients were randomized to receive glutamine (5 g, three times a day) or iso whey for six weeks. Scores of the irritable bowel syndrome symptom severity and quality of life scores were calculated at the beginning and end of the study.
Results: Total severity score of the irritable bowel syndrome (p = 0.015), dissatisfaction with bowel habit (p = 0.001) and abdominal pain frequency (p = 0.028) significantly decreased in the glutamine group, compared to the iso whey group. Moreover, the total score of the irritable bowel syndrome symptom severity, abdominal pain frequency and  dissatisfaction with bowel habits respectively decreased by 180, 32 and 38 points, compared to the glutamine group at the beginning of the intervention.
Conclusion: Based on the findings, glutamine supplementation can be suggested as an adjunct therapy with a low FODMAP diet (oligosaccharides, disaccharides, monosaccharides and fermentable polyols) to further relieve symptoms of the patients with irritable bowel syndrome.
Keywords: Irritable bowel syndrome, Glutamine, Whey protein, Low FODMAP
Full-Text [PDF 620 kb]   (430 Downloads)    
Article type: Research | Subject: nutrition
Received: 2021/07/6 | Accepted: 2021/08/10 | Published: 2022/01/2
1. Dimidi E, Rossi M, Whelan K. Irritable bowel syndrome and diet: where are we in 2018? Current opinion in clinical nutrition and metabolic care. 2017;20(6):456-63. [DOI:10.1097/MCO.0000000000000416]
2. Dugum M, Barco K, Garg S. Managing irritable bowel syndrome: The low-FODMAP diet. Cleveland Clinic journal of medicine. 2016;83(9):655-62. [DOI:10.3949/ccjm.83a.14159]
3. Molina-Infante J, Serra J, Fernandez-Bañares F, Mearin F. The low-FODMAP diet for irritable bowel syndrome: Lights and shadows. Gastroenterologia y hepatologia. 2016;39(2):55-65. [DOI:10.1016/j.gastrohep.2015.07.009]
4. Nanayakkara WS, Skidmore PM, O'Brien L, Wilkinson TJ, Gearry RB. Efficacy of the low FODMAP diet for treating irritable bowel syndrome: the evidence to date. Clinical and experimental gastroenterology. 2016;9:131-42. [DOI:10.2147/CEG.S86798]
5. Cozma-Petruţ A, Loghin F, Miere D, Dumitraşcu DL. Diet in irritable bowel syndrome: What to recommend, not what to forbid to patients! World journal of gastroenterology. 2017;23(21):3771-83. [DOI:10.3748/wjg.v23.i21.3771]
6. Portincasa P, Bonfrate L, de Bari O, Lembo A, Ballou S. Irritable bowel syndrome and diet. Gastroenterology report. 2017;5(1):11-9. [DOI:10.1093/gastro/gow047]
7. Wilson B, Rossi M, Dimidi E, Whelan K. Prebiotics in irritable bowel syndrome and other functional bowel disorders in adults: a systematic review and meta-analysis of randomized controlled trials. The American journal of clinical nutrition. 2019;109(4):1098-111. [DOI:10.1093/ajcn/nqy376]
8. Ford AC, Talley NJ. Irritable bowel syndrome. BMJ (Clinical research ed). 2012;345:e5836. [DOI:10.1136/bmj.e5836]
9. Altobelli E, Del Negro V, Angeletti PM, Latella G. Low-FODMAP Diet Improves Irritable Bowel Syndrome Symptoms: A Meta-Analysis. Nutrients. 2017;9(9). [DOI:10.3390/nu9090940]
10. Kim M, Wischmeyer PE. Glutamine. Nutrition in Intensive Care Medicine: Beyond Physiology. 2013;105:90-6. [DOI:10.1159/000341276]
11. Bertrand J, Ghouzali I, Guérin C, Bôle-Feysot C, Gouteux M, Déchelotte P, et al. Glutamine Restores Tight Junction Protein Claudin-1 Expression in Colonic Mucosa of Patients With Diarrhea-Predominant Irritable Bowel Syndrome. JPEN Journal of parenteral and enteral nutrition. 2016;40(8):1170-6. [DOI:10.1177/0148607115587330]
12. Kim MH, Kim H. The Roles of Glutamine in the Intestine and Its Implication in Intestinal Diseases. International journal of molecular sciences. 2017;18(5). [DOI:10.3390/ijms18051051]
13. Zhou Q, Verne ML, Fields JZ, Lefante JJ, Basra S, Salameh H, et al. Randomised placebo-controlled trial of dietary glutamine supplements for postinfectious irritable bowel syndrome. Gut. 2019;68(6):996-1002. [DOI:10.1136/gutjnl-2017-315136]
14. Perna S, Alalwan TA, Alaali Z, Alnashaba T, Gasparri C, Infantino V, et al. The Role of Glutamine in the Complex Interaction between Gut Microbiota and Health: A Narrative Review. International journal of molecular sciences. 2019;20(20). [DOI:10.3390/ijms20205232]
15. Zhang Y, Lu T, Han L, Zhao L, Niu Y, Chen H. L-Glutamine Supplementation Alleviates Constipation during Late Gestation of Mini Sows by Modifying the Microbiota Composition in Feces. BioMed research international. 2017;2017:4862861. [DOI:10.1155/2017/4862861]
16. Nanayakkara WS, Skidmore PM, O'Brien L, Wilkinson TJ, Gearry RB. Efficacy of the low FODMAP diet for treating irritable bowel syndrome: the evidence to date. Clinical and experimental gastroenterology. 2016;9:131. [DOI:10.2147/CEG.S86798]
17. Biesiekierski JR, Rosella O, Rose R, Liels K, Barrett JS, Shepherd SJ, et al. Quantification of fructans, galacto-oligosacharides and other short-chain carbohydrates in processed grains and cereals. Journal of human nutrition and dietetics : the official journal of the British Dietetic Association. 2011;24(2):154-76. [DOI:10.1111/j.1365-277X.2010.01139.x]
18. Muir JG, Rose R, Rosella O, Liels K, Barrett JS, Shepherd SJ, et al. Measurement of short-chain carbohydrates in common Australian vegetables and fruits by high-performance liquid chromatography (HPLC). Journal of agricultural and food chemistry. 2009;57(2):554-65. [DOI:10.1021/jf802700e]
19. Lembo A, Ameen VZ, Drossman DA. Irritable bowel syndrome: toward an understanding of severity. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2005;3(8):717-25. [DOI:10.1016/S1542-3565(05)00157-6]
20. Gholamrezaei A, Zolfaghari B, Farajzadegan Z, Nemati K, Daghaghzadeh H, Tavakkoli H, et al. Linguistic validation of the Irritable Bowel Syndrome-Quality of Life Questionnaire for Iranian patients. Acta medica Iranica. 2011;49(6):390-5.
21. Zhou Q, Zhang B, Verne GN. Intestinal membrane permeability and hypersensitivity in the irritable bowel syndrome. Pain. 2009;146(1-2):41-6. [DOI:10.1016/j.pain.2009.06.017]
22. Dunlop SP, Hebden J, Campbell E, Naesdal J, Olbe L, Perkins AC, et al. Abnormal intestinal permeability in subgroups of diarrhea-predominant irritable bowel syndromes. The American journal of gastroenterology. 2006;101(6):1288-94. [DOI:10.1111/j.1572-0241.2006.00672.x]
23. Zhou Q, Souba WW, Croce CM, Verne GN. MicroRNA-29a regulates intestinal membrane permeability in patients with irritable bowel syndrome. Gut. 2010;59(6):775-84. [DOI:10.1136/gut.2009.181834]
24. Deters BJ, Saleem M. The role of glutamine in supporting gut health and neuropsychiatric factors. Food Science and Human Wellness. 2021;10(2):149-54. [DOI:10.1016/j.fshw.2021.02.003]
25. Pope JL, Bhat AA, Sharma A, Ahmad R, Krishnan M, Washington MK, et al. Claudin-1 regulates intestinal epithelial homeostasis through the modulation of Notch-signalling. Gut. 2014;63(4):622-34. [DOI:10.1136/gutjnl-2012-304241]
26. Zhou Q, Verne GN. Reply: To PMID 25277410. Gastroenterology. 2015;148(5):1080-1. [DOI:10.1053/j.gastro.2015.03.030]
27. Martínez C, Vicario M, Ramos L, Lobo B, Mosquera JL, Alonso C, et al. The jejunum of diarrhea-predominant irritable bowel syndrome shows molecular alterations in the tight junction signaling pathway that are associated with mucosal pathobiology and clinical manifestations. The American journal of gastroenterology. 2012;107(5):736-46. [DOI:10.1038/ajg.2011.472]
28. Bertiaux-Vandaële N, Youmba SB, Belmonte L, Lecleire S, Antonietti M, Gourcerol G, et al. The expression and the cellular distribution of the tight junction proteins are altered in irritable bowel syndrome patients with differences according to the disease subtype. The American journal of gastroenterology. 2011;106(12):2165-73. [DOI:10.1038/ajg.2011.257]
29. Ng QX, Soh AYS, Loke W, Lim DY, Yeo WS. The role of inflammation in irritable bowel syndrome (IBS). Journal of inflammation research. 2018;11:345-9. [DOI:10.2147/JIR.S174982]
30. Li M, Oshima T, Ito C, Yamada M, Tomita T, Fukui H, et al. Glutamine Blocks Interleukin-13-Induced Intestinal Epithelial Barrier Dysfunction. Digestion. 2021;102(2):170-9.
31. Dupont HL. Review article: evidence for the role of gut microbiota in irritable bowel syndrome and its potential influence on therapeutic targets. Alimentary pharmacology & therapeutics. 2014;39(10):1033-42. [DOI:10.1111/apt.12728]
32. Lee KN, Lee OY. Intestinal microbiota in pathophysiology and management of irritable bowel syndrome. World journal of gastroenterology. 2014;20(27):8886-97. [DOI:10.3748/wjg.v20.i10.2456]
33. Collins SM. A role for the gut microbiota in IBS. Nature reviews Gastroenterology & hepatology. 2014;11(8):497-505. [DOI:10.1038/nrgastro.2014.40]
34. Jeffery IB, Quigley EM, Öhman L, Simrén M, O'Toole PW. The microbiota link to irritable bowel syndrome: an emerging story. Gut microbes. 2012;3(6):572-6. [DOI:10.4161/gmic.21772]
35. Schanuel CM, Dias EN, Ferreira AP. Glutamine as A Therapeutic Strategy in Inflammatory Bowel Diseases: A Systematic Review. Gastroint Hepatol Dig Dis. 2019;2(2):1-6. [DOI:10.33425/2639-9334.1033]
36. Benjamin J, Makharia G, Ahuja V, Anand Rajan KD, Kalaivani M, Gupta SD, et al. Glutamine and whey protein improve intestinal permeability and morphology in patients with Crohn's disease: a randomized controlled trial. Digestive diseases and sciences. 2012;57(4):1000-12. [DOI:10.1007/s10620-011-1947-9]
Send email to the article author

Add your comments about this article
Your username or Email:


XML   Persian Abstract   Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Rastgoo S, Ebrahimi Daryani N, Hekmatdoost A. Effects of Glutamine Supplementation against Iso Whey Protein on Clinical Symptoms and Quality of Life of the Patients with Irritable Bowel Syndrome. Iranian J Nutr Sci Food Technol 2022; 16 (4) :19-28
URL: http://nsft.sbmu.ac.ir/article-1-3316-en.html

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 16, Issue 4 (Winter 2022) Back to browse issues page
Iranian Journal of  Nutrition Sciences and Food  Technology
Persian site map - English site map - Created in 0.04 seconds with 37 queries by YEKTAWEB 4652